HU 211

• CAT Number: R060139
• CAS Number: 112924-45-5
• Molecular Formula: C25H38O3
• Molecular Weight: 386.58
• Purity: ≥95%
• Synonyms: (6aS,10aS)-3-(1,1-Dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9-methanol;(6aS-trans)-3-(1,1-Dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9-methanol; (+)-HU-210; Dexanabinol
• Target: NMDA Receptor
• Solubility: Soluble in DMSO > 10 mM
• Storage: Store at -20℃
• IUPAC Name: (6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
• InChI: InChI=1S/C25H38O3/c1-6-7-8-9-12-24(2,3)18-14-21(27)23-19-13-17(16-26)10-11-20(19)25(4,5)28-22(23)15-18/h10,14-15,19-20,26-27H,6-9,11-13,16H2,1-5H3/t19-,20-/m0/s1
• InChIKey: SSQJFGMEZBFMNV-PMACEKPBSA-N
• SMILES: CCCCCCC(C)(C)C1=CC2=C(C3CC(=CCC3C(O2)(C)C)CO)C(=C1)O

HU 211, also known as dexanabinol, is a synthetic, non-psychoactive cannabinoid derivative originally developed for its neuroprotective properties. It has shown potential in treating brain trauma by reducing brain swelling and inflammation. Unlike other cannabinoids, HU 211 does not bind to the typical cannabinoid receptors, making it free from psychoactive effects. This compound has been explored in clinical trials for its potential therapeutic benefits in stroke and head injury, as well as for its anti-inflammatory and antioxidant properties.